Antepartum vaginal Candida colonization and the risk for obstetrical tears

References

• Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. 2010. MMWR Recomm Rep. 2010;59(RR–12):1–110.
   PubMedGoogle Scholar
• Goldacre MJ, Watt B, Loudon N, et al. Vaginal microbial flora in normal young women. Br Med J. 1979;1(6176):1450–1453.
   PubMedGoogle Scholar
• Tibaldi C, Cappello N, Latino MA, et al. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect. 2009;15(7):670–679.
   PubMed Web of Science ®Google Scholar
• Odds FC. Candidosis of the genitalia. In: Odds FC, editor. Candida and candidosis: a review and bibliography. 2nd ed. London: Bailliere Tindall; 1988. p. 124.
   Google Scholar
• Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971.
   PubMed Web of Science ®Google Scholar
• Mendling W, Brasch J, Cornely OA, et al. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses. 2015;58(Suppl 1):1–15.
   PubMedGoogle Scholar
• Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15–21.
   PubMed Web of Science ®Google Scholar
• Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67(3):400–28.
   PubMed Web of Science ®Google Scholar
• Schaller M, Bein M, Korting HC, et al. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun. 2003;71(6):3227–3234.
   PubMed Web of Science ®Google Scholar
• Nyirjesy P, Zhao Y, Ways K, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173–1178.
   PubMed Web of Science ®Google Scholar
• Van de Wijgert JH, Verwijs MC, Turner AN, et al. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS. 2013;27(13):2141–2153.
   PubMed Web of Science ®Google Scholar
• De Seta F, Restaino S, Banco R, et al. Effects of estroprogestins containing natural estrogen on vaginal flora. Gynecol Endocrinol. 2014;30(11):830–835.
   PubMed Web of Science ®Google Scholar
• De Seta F, Restaino S, De Santo D, et al. Effects of hormonal contraception on vaginal flora. Contraception. 2012;86(5):526–529.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Capuzzo E, Nicola S, et al. The impact of oral contraception on vulvovaginal candidiasis. Contraception. 1995;51(5):293–297.
   PubMed Web of Science ®Google Scholar
• Fischer G, Bradford J. Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy. J Low Genit Tract Dis. 2011;15(4):263–267.
   PubMed Web of Science ®Google Scholar
• Farr A, Kiss H, Holzer I, et al. Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome. Acta Obstet Gynecol Scand. 2015;94(9):989–996.
   PubMed Web of Science ®Google Scholar
• Mendling W, Brasch J; German Society for Gynecology and Obstetrics; Working Group for Infections and Infectimmunology in Gynecology and Obstetrics; German Society of Dermatology, the Board of German Dermatologists; German Speaking Mycological Society. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mycoses. 2012;55(3):1–13.
   PubMedGoogle Scholar
• Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001;4(4):CD000225.
   Google Scholar
• Cotch MF, Hillier SL, Gibbs RS, et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1998;178(2):374–380.
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Tóth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology. 1999;10(4):437–440.
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Fladung B, Vargha P. Preterm birth reduction after clotrimazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004;116(2):157–163.
   PubMed Web of Science ®Google Scholar
• Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ. 2004;329(7462):371.
   PubMedGoogle Scholar
• Hay P, Czeizel AE. Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):403–409.
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Puhó EH, Kazy Z. The use of data set of the Hungarian case-control surveillance of congenital abnormalities for evaluation of birth outcomes beyond birth defects. Cent Eur J Public Health. 2007;15(4):147–153.
   PubMedGoogle Scholar
• Roberts CL, Rickard K, Kotsiou G, et al. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Preg Childbirth. 2011;11:18.
   PubMed Web of Science ®Google Scholar
• Gabbe SG, Niebyl JR, Galan HL, et al. (editors). Obstetrics: normal and problem pregnancies. 6th ed. Philadelphia: Elsevier Saunders; 2012.
   Google Scholar
• Borello-France D, Burgio KL, Richter HE, et al. Fecal and urinary incontinence in primiparous women. Obstet Gynecol. 2006;108(4):863–872.
   PubMed Web of Science ®Google Scholar
• LaCross A, Groff M, Smaldone A. Obstetric anal sphincter injury and anal incontinence following vaginal birth: a systematic review and meta-analysis. J Midwif Womens Health. 2015;60(1):37–47.
   PubMed Web of Science ®Google Scholar
• Beckmann MM, Stock OM. Antenatal perineal massage for reducing perineal trauma. Cochrane Database Syst Rev. 2013;4(4):CD005123
   Google Scholar
• Boggs EW, Berger H, Urquia M, et al. Recurrence of obstetric third-degree and fourth-degree anal sphincter injuries. Obstet Gynecol. 2014;124(6):1128–1134.
   PubMed Web of Science ®Google Scholar
• Kumar R, Ooi C, Nicoll A. Anal incontinence and quality of life following obstetric anal sphincter injury. Arch Gynecol Obstet. 2012;285(3):591–597.
   PubMed Web of Science ®Google Scholar
• Bazi T, Takahashi S, Ismail S, et al. Prevention of pelvic floor disorders: International Urogynecological Association Research and Development Committee opinion. Int Urogynecol J. 2016;27(12):1785–1795.
   PubMed Web of Science ®Google Scholar
• Aasheim V, Nilsen ABV, Reinar LM, et al. Perineal techniques during the second stage of labour for reducing perineal trauma. Cochrane Database Syst Rev. 2011;12:CD006672.
   PubMed Web of Science ®Google Scholar
• Moyes DL, Richardson JP, Naglik JR. Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface. Virulence. 2015;6(4):338–346.
   PubMed Web of Science ®Google Scholar